Bisphenol A alternatives detected in thermal paper in Switzerland, bisphenol F and bisphenol S shown to exhibit endocrine activity using in vitro and in silico tools, no significant endocrine activity found for the alternatives Pergafast® 201 and D-8
Individual-level data published for BPA oral absorption study
New study provides urine and serum profiles of BPA in 10 volunteers who participated in Teeguarden et al. (2015) study
Workshop proceedings on animal testing alternatives
Journal publication presents summary of presentations and key messages from 2017 workshop focused on animal testing alternatives and strategies for food safety assessments
Proceedings of ILSI NA workshop on FCMs
Summary of workshop on ‘Scientific advances and challenges in safety evaluation of food packaging materials’ now published
Study shows oral BPA intake to be of no risk for high exposures
Soup consumption did not lead to higher levels of the active form of BPA in blood of human volunteers, BPA eliminated in urine within 24 hours
FPF Workshop 2019: Non-monotonicity explained
Ana Soto presents biological mechanisms underlying non-monotonic dose-responses, explains why non-monotonicity is ‘useful to organisms, challenging for regulators,’ discusses CLARITY-BPA’s successes and limitations
‘Cocktails’ of endocrine disruptors
New study finds molecular mechanism likely to contribute to toxic ‘cocktail effect’ of EDC mixtures
Inventory list for printed paper and board FCMs
Scientists compile inventory list of chemicals used in printed paper and board FCMs; 1,769 single substances are non-evaluated for their toxicity; of these, 19 substances with actual use confirmed by FACET are included in ECHA’s lists for substances of concern
Aggregate exposure assessment for BPA
Scientists discuss aggregate exposure assessment for bisphenol A; source-to-dose (forward) and biomonitoring-based (backward) calculation resulted in similar estimates; 90% of exposure comes from diet and the remaining 10% mainly from dermal exposure
Petition calls for US FDA to consider cumulative effects
Coalition requests US Food and Drug Administration (FDA) to follow its own mandate to consider cumulative effects of chemicals present during safety assessments; covers chemicals directly added to food, substances migrating from food packaging, substances generally recognized as safe (GRAS); finds only 1 of 877 existing GRAS notifications adhered to requirement